Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 July 2020 | Story Andre Damons | Photo Supplied
Dr Champion N Nyoni.

As yet another testament to the great work being done, as well as the dedication, passion, and hard work of staff members in the School of Nursing at the University of the Free State (UFS), a senior lecturer became the first UFS staff member to win the prestigious Sigma Emerging Nurse Researcher/Scholar award – making him only the third African to win this award. 

“I was overwhelmed to be honoured with this award as the third African to have won it in the history of the awards. To me, this is an indication that the quality of our work in the School of Nursing is top-notch and meets international standards, and that our contribution to nursing science and nursing education is outstanding,” says a proud Dr Champion N. Nyoni on his latest achievement. 

Sigma Theta Tau International (Sigma) is a global honour society for nurses that recognises and advances nursing through research and scholarship. Membership for this society includes a minimum of a master’s qualification and nomination from current members based on your contribution and the potential thereof for nursing at a national and global scale. 

The Emerging Nurse Researcher/Scholar Award, with the purpose of recognising nurses whose research and scholarship has impacted the profession and the people it serves, was introduced in 2015.

No easy process 
It is quite a rigorous process to become eligible for the award, explains Dr Nyoni. “One is nominated by peers who are also part of Sigma; these peers must motivate their nomination by providing evidence related to the research and scholarship of the nominee.” 

“In addition to the numerous reference reports from colleagues in the discipline of nursing, additional referrals are sought from colleagues in other professions (in the health sciences) who have worked and engaged with the research of the nominee. This application process is then evaluated for consideration, among others, by a global panel. I never thought that I would win this award, given the nature of the nomination process, and the heavy funding that other nurse researchers globally receive in comparison to Africa,” says Dr Nyoni.

According to a passionate Dr Nyoni, the award will also give him the energy to continue an academic track, especially in nursing and nursing education, with a focus on improving the quality of nursing education, the quality of nursing graduates, impacting the nursing workforce and thereby influencing the quality of health indicators, especially in Africa, where health systems are nurse-driven. 

Dr Nyoni is appreciative of the nurturing environment and brilliant colleagues in the School of Nursing, who are supporting his research career.

Quality nursing education

"We need quality nurses for quality nursing care, and this should be done through quality nursing education. I hope to use this award as part of a motivation strategy for young nurses to be engaged in scholarship and in academia, as there is a great need, especially in sub-Saharan Africa,” concludes Dr Nyoni.

When he was nominated, Dr Nyoni had close to 15 publications in nursing education and close to 40 presentations at local and international conferences. He also had several awards for his research work, including the Best Education Paper: Senior Category at the Faculty of Health Science’s Research Forum in 2019. 

Dr Nyoni is currently a postdoctoral fellow (the first) in the UFS School of Nursing and serves as chairperson on several boards of directors relating to health professions education in the African region, namely AfrIPEN and SAFRI. He is also supervising several master’s and PhD students.
 
• This award will be presented on Thursday at the International Nursing Research Congress that is now taking place online due to COVID-19.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept